Werewolf Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.

CEO

Daniel J. Hicklin

CEODaniel J. Hicklin

Employees

Employees39

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2017

Founded2017

Employees

Employees39

HOWL Key Statistics

Market cap

147.65M

Market cap147.65M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

81.92K

Average volume81.92K

High today

$5.31

High today$5.31

Low today

$5.00

Low today$5.00

Open price

$5.31

Open price$5.31

Volume

24.73K

Volume24.73K

52 Week high

$18.22

52 Week high$18.22

52 Week low

$3.42

52 Week low$3.42

HOWL Earnings

-$83.36

-$55.57

-$27.79

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, Pre-Market

ActualExpected Nov 9, Pre-Market

Werewolf Therapeutics

Why Robinhood?

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. Show more

HOWL Key Statistics

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.